at the end of the study in vivo organisms were reduced by at least 3 log10 cfu/ml from drug-free growth control chambers by all the antimicrobial regimens tested except for cefoperazone against b. fragilis and ciprofloxacin against the three isolates tested .
C1136254
antimicrobial
C0008809
ciprofloxacin